Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Schertz: The Definitive Guide for Women and Families
If you are a resident of Schertz searching for answers after a breast reconstruction, revision, or augmentation procedure has gone wrong, we recognize the physical and emotional burden you are currently carrying. For many women along the I-35 corridor in Schertz, the path to recovery after a mastectomy or cosmetic surgery is supposed to be a journey toward healing and renewed confidence. Instead, an increasing number of our neighbors in Schertz are discovering that the very medical devices intended to support their bodies—products like acellular dermal matrix (ADM), bioabsorbable scaffolds, and surgical mesh—may be the source of catastrophic complications, chronic pain, and life-altering diagnoses like BIA-ALCL or BIA-SCC.
At Attorney911, led by Ralph Manginello, we have dedicated our careers to protecting the residents of Schertz and the surrounding Comal County area from the consequences of corporate negligence. Our managing partner, Ralph Manginello, has been licensed to practice in Texas for twenty-seven years, bringing a depth of experience that is essential when facing multi-billion-dollar medical device manufacturers. We understand that for a woman in Schertz, a “failed reconstruction” is not just a medical statistic; it is a traumatic event that often requires multiple revision surgeries, extended hospitalizations, and a permanent change in one’s quality of life.
Our team at The Manginello Law Firm, PLLC, including associate attorney Lupe Peña, provides Schertz clients with a unique advantage. Lupe Peña’s background in insurance defense allows us to anticipate the tactics that device manufacturers and their insurers use to devalue claims in Schertz. Furthermore, the bilingual representation we offer ensures that Schertz’s Spanish-speaking community has direct, interpreter-free access to justice. Whether you received your care at a major medical center in nearby San Antonio or a specialist clinic serving Schertz, we are here to provide the sophisticated doctrinal and scientific advocacy your case demands.
When you are ready to discuss your situation, we invite you to call us at 1-888-ATTY-911 for a completely free and confidential consultation. We handle these cases on a contingency fee basis, meaning we never charge you a fee unless we recover compensation for you.
The Regulatory Failure Impacting Schertz Patients: 510(k) and “Predicate Creep”
The fundamental reason so many women in Schertz were never warned about the risks of products like GalaFLEX, Phasix, AlloDerm, or Strattice is a structural failure in the FDA’s regulatory framework. Most of the surgical mesh and scaffold products used in breast surgery today entered the market through the 510(k) premarket notification pathway, as defined in 21 USC §360c and 21 CFR Part 807 Subpart E.
What patients in Schertz need to understand is that 510(k) clearance is not the same as FDA “approval.” Unlike the rigorous Premarket Approval (PMA) process required for Class III devices under 21 CFR Part 814, the 510(k) pathway only requires a manufacturer to show that their device is “substantially equivalent” to a “predicate device” already on the market. In many cases, the manufacturers of these scaffolds and meshes cited predicates that were never intended for use in breast tissue. For example, the manufacturer of GalaFLEX—a poly-4-hydroxybutyrate (P4HB) scaffold—cited a surgical suture as one of its predicates.
This phenomenon, known as “predicate creep,” has allowed materials never clinically tested in human breast tissue to enter operating rooms in the Schertz area and across the country. Because these products are Class II devices, manufacturers often bypassed large-scale clinical trials before they were implanted in women in Schertz. Federal law, specifically 21 CFR §803.10 and Medical Device Reporting (MDR) requirements, mandates that manufacturers report adverse events, yet whistleblowers like Dr. Hooman Noorchashm have alleged that some manufacturers withheld critical safety data, including breast cancer recurrences found in their own trials.
We believe that manufacturers who utilized the 510(k) shortcut to market bioabsorbable scaffolds and ADM for unapproved “off-label” breast procedures in Schertz must be held accountable for the foreseeable harm those products cause.
Recognizing Complications: Serious Warning Signs for Schertz Residents
If you have undergone a breast procedure in Schertz or sought reconstruction after a mastectomy at a San Antonio regional hub, you must be aware of the specific failure modes associated with ADM and bioabsorbable scaffolds. Many women in Schertz are told their complications are “normal side effects” of surgery, when in reality, they may be suffering from a device-related injury.
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
BIA-ALCL is a rare but serious T-cell lymphoma that develops in the scar tissue (capsule) around textured breast implants. The World Health Organization has recognized it as a distinct malignancy since 2016. For a woman in Schertz, the symptoms often present as a late-onset seroma—a buildup of fluid around the implant—occurring seven to ten years after the initial surgery. Pathology for BIA-ALCL is hyper-specific: it is typically CD30-positive and ALK-negative. If you are experiencing asymmetric swelling, lumps, or pain in Schertz years after your reconstruction, it is vital to secure a proper biopsy and have your pathology slides reviewed by specialists.
Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC)
More recently, in September 2022 and March 2023, the FDA issued safety communications regarding BIA-SCC, an epithelial tumor found in the implant capsule. Unlike BIA-ALCL, which is strongly associated with textured surfaces, BIA-SCC has been found in both smooth and textured implants. The latency period can be decades long, making long-term monitoring essential for all Schertz patients with implants.
Red Breast Syndrome (RBS) and Endotoxin Science
Red Breast Syndrome is a sterile inflammatory response specific to the use of acellular dermal matrix (ADM) like FlexHD or Strattice. Schertz patients often report a distinct redness of the skin over the area where the ADM was placed. Scientific literature, including studies by Nguyen et al. (2019), suggests this is an endotoxin-mediated response. Even though the ADM is “sterilized,” bacterial endotoxins (lipopolysaccharides) can remain on the graft, triggering a persistent immune reaction in the woman’s body. If you are in Schertz and your “infection” never responded to antibiotics, it may actually be Red Breast Syndrome caused by defective ADM.
Reconstruction Failure and Tissue Necrosis
Many of our clients in Schertz have experienced skin-flap necrosis—the death of breast tissue—or wound dehiscence after the use of a scaffold or ADM. When products like GalaFLEX or Phasix fail to provide the promised mechanical support or interfere with the body’s natural healing, the result can be a total loss of the reconstruction, leaving the woman with permanent disfigurement and the need for complex “salvage” surgeries using her own tissue, such as a DIEP flap or latissimus dorsi flap.
If you are experiencing any of these symptoms in Schertz, our firm can help you navigate the process of requesting your operative reports and device implant stickers to identify the specific brands used in your body. Call 888-ATTY-911 for professional guidance.
The Legal Framework for Schertz Victims: Texas Product Liability Law
Filing a lawsuit for a defective medical device in Schertz requires an attorney who truly understands the intersection of Texas state law and federal preemption doctrine. Because these devices are 510(k)-cleared Class II products, they are governed by the landmark Supreme Court decision in Medtronic v. Lohr (1996), which establishes that state-law claims for these devices are generally not preempted.
For Schertz residents, the following legal factors are critical:
- The Statute of Limitations: In Texas, you generally have two years from the date of your injury to file a lawsuit. However, the “discovery rule” may apply if you could not have reasonably known the device was the cause of your injury. If you only recently learned about the FDA’s warnings or a manufacturer recall while living in Schertz, your clock may have started more recently.
- Strict Liability and Failure to Warn: We argue that manufacturers are strictly liable when they sell a product in a “defective condition unreasonably dangerous” to the user. This includes a failure to warn the patient and her surgeon in Schertz about the specific risks of off-label use in breast tissue.
- The Learned Intermediary Doctrine: Manufacturers often try to hide behind the surgeon, claiming they only had a duty to warn the doctor. However, when a company engages in aggressive off-label marketing to Schertz-area surgeons—sending sales representatives into operating rooms or sponsoring biased medical education—they may lose this protection.
- Parallel Claims: After the Riegel v. Medtronic (2008) decision, we focus on “parallel claims,” showing that the manufacturer violated federal FDA requirements (such as 21 CFR Part 803 reporting duties) in a way that also violates Texas state law.
Our firm is currently lead counsel in high-profile institutional liability cases like Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 in damages. We bring this same level of aggressive, current litigation capability to every defective device case we handle for Schertz victims.
Why Experience Matters for Your Schertz Case
A generalist personal injury firm might not know that BIA-ALCL requires CD30+ immunohistochemistry for confirmation, or they might not understand the hydrolysis kinetics of P4HB scaffolds. At Attorney911, we pride ourselves on being the sophisticated choice for Schertz.
Choosing Ralph Manginello and his team means choosing a firm with:
- A Proven Track Record: Ralph Manginello holds an Avvo Rating of 8.2 and a Martindale-Hubbell Preeminent 5.0 rating. Our firm has earned hundreds of cumulative five-star reviews on Birdeye, reflecting our commitment to the individuals we serve in Schertz.
- Federal Court Admission: We are admitted to the U.S. District Court for the Southern District of Texas and are equipped to handle federal MDL (Multidistrict Litigation) cases, such as the Allergan BIOCELL MDL 2921 currently before Judge Brian R. Martinotti.
- Technical Savvy: We understand the “predicate creep” problems with GalaFLEX and the MAUDE adverse event reports involving AlloMax and FlexHD.
- Service Ethic: Ralph Manginello is a member of the Pro Bono College of the State Bar of Texas, a recognition reserved for those who exceed the bar’s aspirational goals for service.
We treat every woman in Schertz as an individual, not a case number. We recognize the “financial toxicity” that medical complications can bring to a Schertz household, which is why we offer our “No Win, No Fee” guarantee.
Frequently Asked Questions for Schertz Residents
How do I find out which brand of mesh or ADM was used in my Schertz surgery?
Hospitals in the Schertz and San Antonio areas are required to maintain records of implanted devices. You have a legal right to your full operative report and the “implant log,” which should contain stickers with the Unique Device Identifier (UDI), brand name, and lot number. We can help Schertz clients secure these records if they are meeting resistance.
Is it too late to file a claim in Schertz if my surgery was five years ago?
Not necessarily. Under the Texas discovery rule, the statute of limitations may not begin to run until you discovered—or reasonably should have discovered—the link between your complication and the defective device. If you are a Schertz resident who only recently received a BIA-ALCL diagnosis or learned about the 2023 FDA labeling updates, you should contact us immediately at 1-888-288-9911 for an analysis of your deadlines.
Who do we sue? My surgeon is a good person.
In most cases, the primary defendant is the device manufacturer (such as AbbVie/Allergan, Becton Dickinson, or Integra LifeSciences). While we examine every aspect of a Schertz case, defective product litigation focuses on the company that designed, marketed, and failed to warn about the product.
What is the “internal bra” technique I’ve heard about in Schertz?
The “internal bra” is a marketing term often used for mastopexy (breast lift) or reconstruction procedures where a scaffold like GalaFLEX is used to reinforce the lower pole of the breast. Many Schertz patients were never told this use was “off-label” and lacked long-term safety data for cosmetic applications.
Hablamos Español?
Sí. Lupe Peña es un abogado de Attorney911 que habla español con fluidez. Realizamos consultas completas en español para asegurar que las familias de Schertz entiendan sus derechos legales sin barreras de idioma.
Understanding the Allergan BIOCELL Recall and MDL 2921 for Schertz Patients
For many women in Schertz, the most recognizable name in this litigation is Allergan. In July 2019, the FDA requested that Allergan recall all BIOCELL textured breast implants and tissue expanders. This recall was prompted by data showing that Allergan’s textured surface carried a BIA-ALCL risk roughly six times higher than other manufacturers.
The consolidated federal litigation (MDL 2921) is currently unfolding in the District of New Jersey. As of late 2025, over 1,400 cases have been filed. For a woman in Schertz who has been diagnosed with BIA-ALCL, or even one who is facing the decision of whether to explant their recalled devices, the path forward involves sophisticated coordination with this national litigation.
At Attorney911, we stay current on the Master Case Management Orders and the bellwether trial schedules. The first surgical-explant bellwether trial is currently scheduled for October 19, 2026. This trial will be a watershed moment for Schertz residents seeking justice for textured implant injuries.
Taking the Next Step in Schertz
Dealing with a medical injury is exhausting, especially when you are also managing your family, your career, and your health in Schertz. You may feel like the window for justice is closing, or you may simply be overwhelmed by the complexity of the legal and medical jargon.
We want you to know that you are not alone. Ralph Manginello, Lupe Peña, and the entire team at Attorney911 (The Manginello Law Firm, PLLC) are here to be your advocates. We have the resources to hire independent pathologists to review your slides, the experience to challenge flawed scientific assertions by defense counsel, and the local roots in Texas to see your case through in the courts serving Schertz.
If you believe a defective acellular dermal matrix, bioabsorbable scaffold, or textured implant has caused you harm, please do not hesitate. Call us at 1-888-ATTY-911 (1-888-288-9911) today. We will listen to your story, answer your questions, and help you understand exactly where you stand under Texas law.
Recovery starts with the truth. Let us help you find it.
The Manginello Law Firm, PLLC (Attorney911)
1177 West Loop South, Suite 1600
Houston, Texas 77027
Serving Schertz, San Antonio, Austin, and the State of Texas.
1-888-ATTY-911 | 1-888-288-9911
www.attorney911.com
Past results do not guarantee future outcomes. This content is for educational purposes and does not constitute legal advice until an attorney-client relationship is formally established. We work on a contingency fee basis—no fee unless we recover. Case expenses may apply.
Resources for Schertz Patients
While we handle the legal battle, we encourage Schertz survivors to seek support through independent organizations:
- The PROFILE Registry: Report your BIA-ALCL case at ThePSF.org/PROFILE.
- SHARE Cancer Support: Bilingual support and patient navigators at 1-844-275-7427.
- National Breast Cancer Foundation: Virtual navigation services available for Schertz residents in English and Spanish.
- The Pink Fund: Providing financial assistance for non-medical expenses for breast cancer patients in active treatment.
If you are a resident of Schertz in need of immediate legal assistance, our office is ready to take your call. Hablamos español y estamos aquí para ayudarle. Call 1-888-ATTY-911.
